semaglutide weight loss fda approval New Medication Wegovy™ Approved by the U.S. FDA finds no evidence

Or it could be the placebo effect

This outcome reflects a pattern observed in previous trials targeting the amyloid-beta pathway, prompting renewed scrutiny of the underlying disease mechanisms and therapeutic strategies

Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus

Most probiotic supplements provide at least a few strains, and multi-strain blends in particular show promise in reducing body weight and waist circumference in people with excess weight or obesity, though research is ongoing

doi: 10.3389/fgene.2020.575678 Received 24 June 2020 Accepted 26 August 2020 Published 16 October 2020 Volume 11 - 2020 Edited by Ulrich M